Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

NCT06722495 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

SBRT
Neoadjuvant Immunochemotherapy
LA HNSCC

Interventions

RADIATION: SBRT

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University